Sure competition exists, however, their products have certain features not present in the market currently, along with successful surgeries to back it - now these are facts, and not only research based statements.
The competition that does exist is all indirect competition and so the company has a very very strong moat. What's important I think is what the markets want (what method do surgeons prefer) ?. Hence Osteopore needs a lot of subject matter experts to educate along with pushing for sales - which they have enough of, they need to be aggressive in sales though.
while cosmetic focus via the Asian market is good, they need to push across other geographies with other products and continue developing. They very much can win some market share because there is no direct competition - what's the threat ?
the proof is in the pudding.
- Forums
- ASX - By Stock
- OSX
- Ann: Non-Renounceable Entitlement Offer Extension
OSX
osteopore limited
Add to My Watchlist
15.4%
!
1.5¢

Ann: Non-Renounceable Entitlement Offer Extension, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.5¢ |
Change
0.002(15.4%) |
Mkt cap ! $3.107M |
Open | High | Low | Value | Volume |
1.5¢ | 1.5¢ | 1.4¢ | $13.82K | 944.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 648717 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.5¢ | 1027816 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 998717 | 0.014 |
10 | 2852224 | 0.013 |
9 | 1346753 | 0.012 |
15 | 2602818 | 0.011 |
20 | 4217886 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.015 | 977816 | 4 |
0.016 | 794093 | 2 |
0.017 | 1585200 | 6 |
0.018 | 1215918 | 4 |
0.019 | 1082647 | 5 |
Last trade - 16.10pm 17/07/2025 (20 minute delay) ? |
Featured News
OSX (ASX) Chart |